The Valence Group Advises IGM on its Sale to Arsenal Capital

September 24th, 2012

The Valence Group has advised IGM on the sale of the company to NY-based private equity firm, Arsenal Capital, that specializes in making investments in middle market specialty industrial, healthcare and financial services companies. The terms of the transaction were not disclosed.

IGM is privately held and produces specialty chemicals for the global UV inks and coatings industry. Its products include monomers, oligomers, photoinitiators, additives and customized specialty compounds. The company was founded in 1999 and is based in Waalwijk, Netherlands, with offices and production facilities in Europe, US, South America and China. In 2012, the company is expected to generate sales of approximately €100 million.

About The Valence Group

The Valence Group is a specialist investment bank offering M&A advisory services exclusively to companies and investors in the chemicals, materials and related sectors. The Valence Group team includes a unique combination of professionals with backgrounds in investment banking, strategic consulting and senior management within the chemicals and materials industries, all focused exclusively on providing M&A advisory services to the chemicals and materials sector. The senior members of The Valence Group have collectively more than 350 years of experience, and have advised on more than 200 closed transactions valued cumulatively over $85 billion and spanning more than 80 different chemicals/materials subsectors. The firm’s offices are located in New York, London and Shanghai.